focus -WSS

focus

author：explore 2025-09-27 12:57:20 - browse：668

An exercise physiologist works with a patient at a cardiac rehab class — Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals, going against growing support for site-neutral payments. Photo illustration: STAT, Photo: Mark Duncan/AP

Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals.

Medicare has admitted it is doing so due to an error in reading federal law, but it also goes against the grain of the current environment, where support for site-neutral payments has never been higher. Some members of Congress and health care experts are pushing for a system that would not pay hospital outpatient departments more for identical services that are provided in lower-priced physician offices.

Naturally, hospitals cheered regulators for increasing payments. But they don’t want the government to stop there. They also want Medicare to retroactively reprocess all underpaid heart rehab sessions, and they are using this proposal as a way to reiterate their desire to kill all policies that would pay hospital-owned clinics the same as physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Do digital therapeutics have a future in medicine?

WSS

Hearing on Medicare drug price negotiation gets unusually heated

How AI helped researchers track recovery from depression

Drug for rare kidney disease narrowly misses mark in clinical trial

FDA drug safety: Singulair case shows systemic surveillance flaws

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

FDA panel to weigh approval of NurOwn, controversial ALS drug

Wikipedia

focus

hotspot

Cancer drug shortages should be causing more outrage

FDA panel to weigh approval of NurOwn, controversial ALS drug

Jerome Adams on the need for new antivirals for Covid

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Peter Hotez and the public health issue of online harassment

Do digital therapeutics have a future in medicine?

Apple is now the first public company to be valued at $3 trillion

Changes to biosimilar regulatory framework must prioritize patients

23andMe had bad news about my health. I wish a person had delivered it

Woodcock on FDA’s accelerated approval and her next chapter

leisure time

General Catalyst, Summa Health deal will turn on physician buy

STAT Virtual Event: Putting AI to the Test

Senate HELP committee spars over health care workforce policies

Biden administration opens offers in Medicare drug price negotiations

CDC advisers recommend seasonal use of Pfizer RSV shot

Covid misinformation case heads to Supreme Court

focus

entertainment

Wikipedia

Wikipedia